Global Azacitidine Drug Market Growth 2025-2031
The global Azacitidine Drug market size is predicted to grow from US$ 95.6 million in 2025 to US$ 118 million in 2031; it is expected to grow at a CAGR of 3.5% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Azacitidine is used to treat myelodysplastic syndromes (MDS), a number of disorders in which not enough healthy blood cells are produced in the bone marrow, leaving patients with low blood counts. In healthy bone marrow, stem cells become red blood cells, white blood cells or platelets. In MDS, this process is dysfunctional.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Azacitidine Drug Industry Forecast” looks at past sales and reviews total world Azacitidine Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Azacitidine Drug sales for 2025 through 2031. With Azacitidine Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Azacitidine Drug industry.
This Insight Report provides a comprehensive analysis of the global Azacitidine Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Azacitidine Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Azacitidine Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Azacitidine Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Azacitidine Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Azacitidine Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Azacitidine Drug market?
What factors are driving Azacitidine Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Azacitidine Drug market opportunities vary by end market size?
How does Azacitidine Drug break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Azacitidine is used to treat myelodysplastic syndromes (MDS), a number of disorders in which not enough healthy blood cells are produced in the bone marrow, leaving patients with low blood counts. In healthy bone marrow, stem cells become red blood cells, white blood cells or platelets. In MDS, this process is dysfunctional.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Azacitidine Drug Industry Forecast” looks at past sales and reviews total world Azacitidine Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Azacitidine Drug sales for 2025 through 2031. With Azacitidine Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Azacitidine Drug industry.
This Insight Report provides a comprehensive analysis of the global Azacitidine Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Azacitidine Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Azacitidine Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Azacitidine Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Azacitidine Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Azacitidine Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Vidaza®
- Generic Vidaza®
- Refractory anemia (RA)
- Refractory anemia with excess blasts (RAEB)
- Chronic myelomonocytic leukemia (CMMoL)
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Celgene
- Mylan
- Shilpa Medicare
- Accord Healthcare
- Natco Pharma
- Dr. Reddy's Laboratories
- MBA Pharmaceuticals Pvt Ltd
- Taj Generics
- Getwell Oncology
- EVER Pharma
- Xpreza
- Shubham Pharmaceutical
- Rizochem Pharmaceutical
What is the 10-year outlook for the global Azacitidine Drug market?
What factors are driving Azacitidine Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Azacitidine Drug market opportunities vary by end market size?
How does Azacitidine Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Azacitidine Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Azacitidine Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Azacitidine Drug by Country/Region, 2020, 2024 & 2031
2.2 Azacitidine Drug Segment by Type
2.2.1 Vidaza®
2.2.2 Generic Vidaza®
2.3 Azacitidine Drug Sales by Type
2.3.1 Global Azacitidine Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Azacitidine Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Azacitidine Drug Sale Price by Type (2020-2025)
2.4 Azacitidine Drug Segment by Application
2.4.1 Refractory anemia (RA)
2.4.2 Refractory anemia with excess blasts (RAEB)
2.4.3 Chronic myelomonocytic leukemia (CMMoL)
2.4.4 Others
2.5 Azacitidine Drug Sales by Application
2.5.1 Global Azacitidine Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Azacitidine Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Azacitidine Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Azacitidine Drug Breakdown Data by Company
3.1.1 Global Azacitidine Drug Annual Sales by Company (2020-2025)
3.1.2 Global Azacitidine Drug Sales Market Share by Company (2020-2025)
3.2 Global Azacitidine Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Azacitidine Drug Revenue by Company (2020-2025)
3.2.2 Global Azacitidine Drug Revenue Market Share by Company (2020-2025)
3.3 Global Azacitidine Drug Sale Price by Company
3.4 Key Manufacturers Azacitidine Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Azacitidine Drug Product Location Distribution
3.4.2 Players Azacitidine Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AZACITIDINE DRUG BY GEOGRAPHIC REGION
4.1 World Historic Azacitidine Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Azacitidine Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Azacitidine Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Azacitidine Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Azacitidine Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Azacitidine Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Azacitidine Drug Sales Growth
4.4 APAC Azacitidine Drug Sales Growth
4.5 Europe Azacitidine Drug Sales Growth
4.6 Middle East & Africa Azacitidine Drug Sales Growth
5 AMERICAS
5.1 Americas Azacitidine Drug Sales by Country
5.1.1 Americas Azacitidine Drug Sales by Country (2020-2025)
5.1.2 Americas Azacitidine Drug Revenue by Country (2020-2025)
5.2 Americas Azacitidine Drug Sales by Type (2020-2025)
5.3 Americas Azacitidine Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Azacitidine Drug Sales by Region
6.1.1 APAC Azacitidine Drug Sales by Region (2020-2025)
6.1.2 APAC Azacitidine Drug Revenue by Region (2020-2025)
6.2 APAC Azacitidine Drug Sales by Type (2020-2025)
6.3 APAC Azacitidine Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Azacitidine Drug by Country
7.1.1 Europe Azacitidine Drug Sales by Country (2020-2025)
7.1.2 Europe Azacitidine Drug Revenue by Country (2020-2025)
7.2 Europe Azacitidine Drug Sales by Type (2020-2025)
7.3 Europe Azacitidine Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Azacitidine Drug by Country
8.1.1 Middle East & Africa Azacitidine Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Azacitidine Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Azacitidine Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Azacitidine Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Azacitidine Drug
10.3 Manufacturing Process Analysis of Azacitidine Drug
10.4 Industry Chain Structure of Azacitidine Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Azacitidine Drug Distributors
11.3 Azacitidine Drug Customer
12 WORLD FORECAST REVIEW FOR AZACITIDINE DRUG BY GEOGRAPHIC REGION
12.1 Global Azacitidine Drug Market Size Forecast by Region
12.1.1 Global Azacitidine Drug Forecast by Region (2026-2031)
12.1.2 Global Azacitidine Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Azacitidine Drug Forecast by Type (2026-2031)
12.7 Global Azacitidine Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Celgene
13.1.1 Celgene Company Information
13.1.2 Celgene Azacitidine Drug Product Portfolios and Specifications
13.1.3 Celgene Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Celgene Main Business Overview
13.1.5 Celgene Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Azacitidine Drug Product Portfolios and Specifications
13.2.3 Mylan Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Shilpa Medicare
13.3.1 Shilpa Medicare Company Information
13.3.2 Shilpa Medicare Azacitidine Drug Product Portfolios and Specifications
13.3.3 Shilpa Medicare Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Shilpa Medicare Main Business Overview
13.3.5 Shilpa Medicare Latest Developments
13.4 Accord Healthcare
13.4.1 Accord Healthcare Company Information
13.4.2 Accord Healthcare Azacitidine Drug Product Portfolios and Specifications
13.4.3 Accord Healthcare Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Accord Healthcare Main Business Overview
13.4.5 Accord Healthcare Latest Developments
13.5 Natco Pharma
13.5.1 Natco Pharma Company Information
13.5.2 Natco Pharma Azacitidine Drug Product Portfolios and Specifications
13.5.3 Natco Pharma Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Natco Pharma Main Business Overview
13.5.5 Natco Pharma Latest Developments
13.6 Dr. Reddy's Laboratories
13.6.1 Dr. Reddy's Laboratories Company Information
13.6.2 Dr. Reddy's Laboratories Azacitidine Drug Product Portfolios and Specifications
13.6.3 Dr. Reddy's Laboratories Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Dr. Reddy's Laboratories Main Business Overview
13.6.5 Dr. Reddy's Laboratories Latest Developments
13.7 MBA Pharmaceuticals Pvt Ltd
13.7.1 MBA Pharmaceuticals Pvt Ltd Company Information
13.7.2 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Product Portfolios and Specifications
13.7.3 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 MBA Pharmaceuticals Pvt Ltd Main Business Overview
13.7.5 MBA Pharmaceuticals Pvt Ltd Latest Developments
13.8 Taj Generics
13.8.1 Taj Generics Company Information
13.8.2 Taj Generics Azacitidine Drug Product Portfolios and Specifications
13.8.3 Taj Generics Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Taj Generics Main Business Overview
13.8.5 Taj Generics Latest Developments
13.9 Getwell Oncology
13.9.1 Getwell Oncology Company Information
13.9.2 Getwell Oncology Azacitidine Drug Product Portfolios and Specifications
13.9.3 Getwell Oncology Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Getwell Oncology Main Business Overview
13.9.5 Getwell Oncology Latest Developments
13.10 EVER Pharma
13.10.1 EVER Pharma Company Information
13.10.2 EVER Pharma Azacitidine Drug Product Portfolios and Specifications
13.10.3 EVER Pharma Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 EVER Pharma Main Business Overview
13.10.5 EVER Pharma Latest Developments
13.11 Xpreza
13.11.1 Xpreza Company Information
13.11.2 Xpreza Azacitidine Drug Product Portfolios and Specifications
13.11.3 Xpreza Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Xpreza Main Business Overview
13.11.5 Xpreza Latest Developments
13.12 Shubham Pharmaceutical
13.12.1 Shubham Pharmaceutical Company Information
13.12.2 Shubham Pharmaceutical Azacitidine Drug Product Portfolios and Specifications
13.12.3 Shubham Pharmaceutical Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Shubham Pharmaceutical Main Business Overview
13.12.5 Shubham Pharmaceutical Latest Developments
13.13 Rizochem Pharmaceutical
13.13.1 Rizochem Pharmaceutical Company Information
13.13.2 Rizochem Pharmaceutical Azacitidine Drug Product Portfolios and Specifications
13.13.3 Rizochem Pharmaceutical Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Rizochem Pharmaceutical Main Business Overview
13.13.5 Rizochem Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Azacitidine Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Azacitidine Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Azacitidine Drug by Country/Region, 2020, 2024 & 2031
2.2 Azacitidine Drug Segment by Type
2.2.1 Vidaza®
2.2.2 Generic Vidaza®
2.3 Azacitidine Drug Sales by Type
2.3.1 Global Azacitidine Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Azacitidine Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Azacitidine Drug Sale Price by Type (2020-2025)
2.4 Azacitidine Drug Segment by Application
2.4.1 Refractory anemia (RA)
2.4.2 Refractory anemia with excess blasts (RAEB)
2.4.3 Chronic myelomonocytic leukemia (CMMoL)
2.4.4 Others
2.5 Azacitidine Drug Sales by Application
2.5.1 Global Azacitidine Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Azacitidine Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Azacitidine Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Azacitidine Drug Breakdown Data by Company
3.1.1 Global Azacitidine Drug Annual Sales by Company (2020-2025)
3.1.2 Global Azacitidine Drug Sales Market Share by Company (2020-2025)
3.2 Global Azacitidine Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Azacitidine Drug Revenue by Company (2020-2025)
3.2.2 Global Azacitidine Drug Revenue Market Share by Company (2020-2025)
3.3 Global Azacitidine Drug Sale Price by Company
3.4 Key Manufacturers Azacitidine Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Azacitidine Drug Product Location Distribution
3.4.2 Players Azacitidine Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AZACITIDINE DRUG BY GEOGRAPHIC REGION
4.1 World Historic Azacitidine Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Azacitidine Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Azacitidine Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Azacitidine Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Azacitidine Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Azacitidine Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Azacitidine Drug Sales Growth
4.4 APAC Azacitidine Drug Sales Growth
4.5 Europe Azacitidine Drug Sales Growth
4.6 Middle East & Africa Azacitidine Drug Sales Growth
5 AMERICAS
5.1 Americas Azacitidine Drug Sales by Country
5.1.1 Americas Azacitidine Drug Sales by Country (2020-2025)
5.1.2 Americas Azacitidine Drug Revenue by Country (2020-2025)
5.2 Americas Azacitidine Drug Sales by Type (2020-2025)
5.3 Americas Azacitidine Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Azacitidine Drug Sales by Region
6.1.1 APAC Azacitidine Drug Sales by Region (2020-2025)
6.1.2 APAC Azacitidine Drug Revenue by Region (2020-2025)
6.2 APAC Azacitidine Drug Sales by Type (2020-2025)
6.3 APAC Azacitidine Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Azacitidine Drug by Country
7.1.1 Europe Azacitidine Drug Sales by Country (2020-2025)
7.1.2 Europe Azacitidine Drug Revenue by Country (2020-2025)
7.2 Europe Azacitidine Drug Sales by Type (2020-2025)
7.3 Europe Azacitidine Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Azacitidine Drug by Country
8.1.1 Middle East & Africa Azacitidine Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Azacitidine Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Azacitidine Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Azacitidine Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Azacitidine Drug
10.3 Manufacturing Process Analysis of Azacitidine Drug
10.4 Industry Chain Structure of Azacitidine Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Azacitidine Drug Distributors
11.3 Azacitidine Drug Customer
12 WORLD FORECAST REVIEW FOR AZACITIDINE DRUG BY GEOGRAPHIC REGION
12.1 Global Azacitidine Drug Market Size Forecast by Region
12.1.1 Global Azacitidine Drug Forecast by Region (2026-2031)
12.1.2 Global Azacitidine Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Azacitidine Drug Forecast by Type (2026-2031)
12.7 Global Azacitidine Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Celgene
13.1.1 Celgene Company Information
13.1.2 Celgene Azacitidine Drug Product Portfolios and Specifications
13.1.3 Celgene Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Celgene Main Business Overview
13.1.5 Celgene Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Azacitidine Drug Product Portfolios and Specifications
13.2.3 Mylan Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Shilpa Medicare
13.3.1 Shilpa Medicare Company Information
13.3.2 Shilpa Medicare Azacitidine Drug Product Portfolios and Specifications
13.3.3 Shilpa Medicare Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Shilpa Medicare Main Business Overview
13.3.5 Shilpa Medicare Latest Developments
13.4 Accord Healthcare
13.4.1 Accord Healthcare Company Information
13.4.2 Accord Healthcare Azacitidine Drug Product Portfolios and Specifications
13.4.3 Accord Healthcare Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Accord Healthcare Main Business Overview
13.4.5 Accord Healthcare Latest Developments
13.5 Natco Pharma
13.5.1 Natco Pharma Company Information
13.5.2 Natco Pharma Azacitidine Drug Product Portfolios and Specifications
13.5.3 Natco Pharma Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Natco Pharma Main Business Overview
13.5.5 Natco Pharma Latest Developments
13.6 Dr. Reddy's Laboratories
13.6.1 Dr. Reddy's Laboratories Company Information
13.6.2 Dr. Reddy's Laboratories Azacitidine Drug Product Portfolios and Specifications
13.6.3 Dr. Reddy's Laboratories Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Dr. Reddy's Laboratories Main Business Overview
13.6.5 Dr. Reddy's Laboratories Latest Developments
13.7 MBA Pharmaceuticals Pvt Ltd
13.7.1 MBA Pharmaceuticals Pvt Ltd Company Information
13.7.2 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Product Portfolios and Specifications
13.7.3 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 MBA Pharmaceuticals Pvt Ltd Main Business Overview
13.7.5 MBA Pharmaceuticals Pvt Ltd Latest Developments
13.8 Taj Generics
13.8.1 Taj Generics Company Information
13.8.2 Taj Generics Azacitidine Drug Product Portfolios and Specifications
13.8.3 Taj Generics Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Taj Generics Main Business Overview
13.8.5 Taj Generics Latest Developments
13.9 Getwell Oncology
13.9.1 Getwell Oncology Company Information
13.9.2 Getwell Oncology Azacitidine Drug Product Portfolios and Specifications
13.9.3 Getwell Oncology Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Getwell Oncology Main Business Overview
13.9.5 Getwell Oncology Latest Developments
13.10 EVER Pharma
13.10.1 EVER Pharma Company Information
13.10.2 EVER Pharma Azacitidine Drug Product Portfolios and Specifications
13.10.3 EVER Pharma Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 EVER Pharma Main Business Overview
13.10.5 EVER Pharma Latest Developments
13.11 Xpreza
13.11.1 Xpreza Company Information
13.11.2 Xpreza Azacitidine Drug Product Portfolios and Specifications
13.11.3 Xpreza Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Xpreza Main Business Overview
13.11.5 Xpreza Latest Developments
13.12 Shubham Pharmaceutical
13.12.1 Shubham Pharmaceutical Company Information
13.12.2 Shubham Pharmaceutical Azacitidine Drug Product Portfolios and Specifications
13.12.3 Shubham Pharmaceutical Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Shubham Pharmaceutical Main Business Overview
13.12.5 Shubham Pharmaceutical Latest Developments
13.13 Rizochem Pharmaceutical
13.13.1 Rizochem Pharmaceutical Company Information
13.13.2 Rizochem Pharmaceutical Azacitidine Drug Product Portfolios and Specifications
13.13.3 Rizochem Pharmaceutical Azacitidine Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Rizochem Pharmaceutical Main Business Overview
13.13.5 Rizochem Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Azacitidine Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Azacitidine Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Vidaza®
Table 4. Major Players of Generic Vidaza®
Table 5. Global Azacitidine Drug Sales by Type (2020-2025) & (K Units)
Table 6. Global Azacitidine Drug Sales Market Share by Type (2020-2025)
Table 7. Global Azacitidine Drug Revenue by Type (2020-2025) & ($ million)
Table 8. Global Azacitidine Drug Revenue Market Share by Type (2020-2025)
Table 9. Global Azacitidine Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Azacitidine Drug Sale by Application (2020-2025) & (K Units)
Table 11. Global Azacitidine Drug Sale Market Share by Application (2020-2025)
Table 12. Global Azacitidine Drug Revenue by Application (2020-2025) & ($ million)
Table 13. Global Azacitidine Drug Revenue Market Share by Application (2020-2025)
Table 14. Global Azacitidine Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Azacitidine Drug Sales by Company (2020-2025) & (K Units)
Table 16. Global Azacitidine Drug Sales Market Share by Company (2020-2025)
Table 17. Global Azacitidine Drug Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Azacitidine Drug Revenue Market Share by Company (2020-2025)
Table 19. Global Azacitidine Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Azacitidine Drug Producing Area Distribution and Sales Area
Table 21. Players Azacitidine Drug Products Offered
Table 22. Azacitidine Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Azacitidine Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Azacitidine Drug Sales Market Share Geographic Region (2020-2025)
Table 27. Global Azacitidine Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Azacitidine Drug Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Azacitidine Drug Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Azacitidine Drug Sales Market Share by Country/Region (2020-2025)
Table 31. Global Azacitidine Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Azacitidine Drug Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Azacitidine Drug Sales by Country (2020-2025) & (K Units)
Table 34. Americas Azacitidine Drug Sales Market Share by Country (2020-2025)
Table 35. Americas Azacitidine Drug Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Azacitidine Drug Sales by Type (2020-2025) & (K Units)
Table 37. Americas Azacitidine Drug Sales by Application (2020-2025) & (K Units)
Table 38. APAC Azacitidine Drug Sales by Region (2020-2025) & (K Units)
Table 39. APAC Azacitidine Drug Sales Market Share by Region (2020-2025)
Table 40. APAC Azacitidine Drug Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Azacitidine Drug Sales by Type (2020-2025) & (K Units)
Table 42. APAC Azacitidine Drug Sales by Application (2020-2025) & (K Units)
Table 43. Europe Azacitidine Drug Sales by Country (2020-2025) & (K Units)
Table 44. Europe Azacitidine Drug Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Azacitidine Drug Sales by Type (2020-2025) & (K Units)
Table 46. Europe Azacitidine Drug Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Azacitidine Drug Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Azacitidine Drug Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Azacitidine Drug Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Azacitidine Drug Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Azacitidine Drug
Table 52. Key Market Challenges & Risks of Azacitidine Drug
Table 53. Key Industry Trends of Azacitidine Drug
Table 54. Azacitidine Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Azacitidine Drug Distributors List
Table 57. Azacitidine Drug Customer List
Table 58. Global Azacitidine Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Azacitidine Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Azacitidine Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Azacitidine Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Azacitidine Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Azacitidine Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Azacitidine Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Azacitidine Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Azacitidine Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Azacitidine Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Azacitidine Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Azacitidine Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Azacitidine Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Azacitidine Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Celgene Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. Celgene Azacitidine Drug Product Portfolios and Specifications
Table 74. Celgene Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Celgene Main Business
Table 76. Celgene Latest Developments
Table 77. Mylan Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. Mylan Azacitidine Drug Product Portfolios and Specifications
Table 79. Mylan Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Mylan Main Business
Table 81. Mylan Latest Developments
Table 82. Shilpa Medicare Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. Shilpa Medicare Azacitidine Drug Product Portfolios and Specifications
Table 84. Shilpa Medicare Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Shilpa Medicare Main Business
Table 86. Shilpa Medicare Latest Developments
Table 87. Accord Healthcare Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Accord Healthcare Azacitidine Drug Product Portfolios and Specifications
Table 89. Accord Healthcare Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Accord Healthcare Main Business
Table 91. Accord Healthcare Latest Developments
Table 92. Natco Pharma Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Natco Pharma Azacitidine Drug Product Portfolios and Specifications
Table 94. Natco Pharma Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Natco Pharma Main Business
Table 96. Natco Pharma Latest Developments
Table 97. Dr. Reddy's Laboratories Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Dr. Reddy's Laboratories Azacitidine Drug Product Portfolios and Specifications
Table 99. Dr. Reddy's Laboratories Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Dr. Reddy's Laboratories Main Business
Table 101. Dr. Reddy's Laboratories Latest Developments
Table 102. MBA Pharmaceuticals Pvt Ltd Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Product Portfolios and Specifications
Table 104. MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. MBA Pharmaceuticals Pvt Ltd Main Business
Table 106. MBA Pharmaceuticals Pvt Ltd Latest Developments
Table 107. Taj Generics Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Taj Generics Azacitidine Drug Product Portfolios and Specifications
Table 109. Taj Generics Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Taj Generics Main Business
Table 111. Taj Generics Latest Developments
Table 112. Getwell Oncology Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Getwell Oncology Azacitidine Drug Product Portfolios and Specifications
Table 114. Getwell Oncology Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Getwell Oncology Main Business
Table 116. Getwell Oncology Latest Developments
Table 117. EVER Pharma Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. EVER Pharma Azacitidine Drug Product Portfolios and Specifications
Table 119. EVER Pharma Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. EVER Pharma Main Business
Table 121. EVER Pharma Latest Developments
Table 122. Xpreza Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Xpreza Azacitidine Drug Product Portfolios and Specifications
Table 124. Xpreza Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Xpreza Main Business
Table 126. Xpreza Latest Developments
Table 127. Shubham Pharmaceutical Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Shubham Pharmaceutical Azacitidine Drug Product Portfolios and Specifications
Table 129. Shubham Pharmaceutical Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Shubham Pharmaceutical Main Business
Table 131. Shubham Pharmaceutical Latest Developments
Table 132. Rizochem Pharmaceutical Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Rizochem Pharmaceutical Azacitidine Drug Product Portfolios and Specifications
Table 134. Rizochem Pharmaceutical Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Rizochem Pharmaceutical Main Business
Table 136. Rizochem Pharmaceutical Latest Developments
Table 1. Azacitidine Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Azacitidine Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Vidaza®
Table 4. Major Players of Generic Vidaza®
Table 5. Global Azacitidine Drug Sales by Type (2020-2025) & (K Units)
Table 6. Global Azacitidine Drug Sales Market Share by Type (2020-2025)
Table 7. Global Azacitidine Drug Revenue by Type (2020-2025) & ($ million)
Table 8. Global Azacitidine Drug Revenue Market Share by Type (2020-2025)
Table 9. Global Azacitidine Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Azacitidine Drug Sale by Application (2020-2025) & (K Units)
Table 11. Global Azacitidine Drug Sale Market Share by Application (2020-2025)
Table 12. Global Azacitidine Drug Revenue by Application (2020-2025) & ($ million)
Table 13. Global Azacitidine Drug Revenue Market Share by Application (2020-2025)
Table 14. Global Azacitidine Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Azacitidine Drug Sales by Company (2020-2025) & (K Units)
Table 16. Global Azacitidine Drug Sales Market Share by Company (2020-2025)
Table 17. Global Azacitidine Drug Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Azacitidine Drug Revenue Market Share by Company (2020-2025)
Table 19. Global Azacitidine Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Azacitidine Drug Producing Area Distribution and Sales Area
Table 21. Players Azacitidine Drug Products Offered
Table 22. Azacitidine Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Azacitidine Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Azacitidine Drug Sales Market Share Geographic Region (2020-2025)
Table 27. Global Azacitidine Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Azacitidine Drug Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Azacitidine Drug Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Azacitidine Drug Sales Market Share by Country/Region (2020-2025)
Table 31. Global Azacitidine Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Azacitidine Drug Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Azacitidine Drug Sales by Country (2020-2025) & (K Units)
Table 34. Americas Azacitidine Drug Sales Market Share by Country (2020-2025)
Table 35. Americas Azacitidine Drug Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Azacitidine Drug Sales by Type (2020-2025) & (K Units)
Table 37. Americas Azacitidine Drug Sales by Application (2020-2025) & (K Units)
Table 38. APAC Azacitidine Drug Sales by Region (2020-2025) & (K Units)
Table 39. APAC Azacitidine Drug Sales Market Share by Region (2020-2025)
Table 40. APAC Azacitidine Drug Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Azacitidine Drug Sales by Type (2020-2025) & (K Units)
Table 42. APAC Azacitidine Drug Sales by Application (2020-2025) & (K Units)
Table 43. Europe Azacitidine Drug Sales by Country (2020-2025) & (K Units)
Table 44. Europe Azacitidine Drug Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Azacitidine Drug Sales by Type (2020-2025) & (K Units)
Table 46. Europe Azacitidine Drug Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Azacitidine Drug Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Azacitidine Drug Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Azacitidine Drug Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Azacitidine Drug Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Azacitidine Drug
Table 52. Key Market Challenges & Risks of Azacitidine Drug
Table 53. Key Industry Trends of Azacitidine Drug
Table 54. Azacitidine Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Azacitidine Drug Distributors List
Table 57. Azacitidine Drug Customer List
Table 58. Global Azacitidine Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Azacitidine Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Azacitidine Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Azacitidine Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Azacitidine Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Azacitidine Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Azacitidine Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Azacitidine Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Azacitidine Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Azacitidine Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Azacitidine Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Azacitidine Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Azacitidine Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Azacitidine Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Celgene Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. Celgene Azacitidine Drug Product Portfolios and Specifications
Table 74. Celgene Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Celgene Main Business
Table 76. Celgene Latest Developments
Table 77. Mylan Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. Mylan Azacitidine Drug Product Portfolios and Specifications
Table 79. Mylan Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Mylan Main Business
Table 81. Mylan Latest Developments
Table 82. Shilpa Medicare Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. Shilpa Medicare Azacitidine Drug Product Portfolios and Specifications
Table 84. Shilpa Medicare Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Shilpa Medicare Main Business
Table 86. Shilpa Medicare Latest Developments
Table 87. Accord Healthcare Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Accord Healthcare Azacitidine Drug Product Portfolios and Specifications
Table 89. Accord Healthcare Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Accord Healthcare Main Business
Table 91. Accord Healthcare Latest Developments
Table 92. Natco Pharma Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Natco Pharma Azacitidine Drug Product Portfolios and Specifications
Table 94. Natco Pharma Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Natco Pharma Main Business
Table 96. Natco Pharma Latest Developments
Table 97. Dr. Reddy's Laboratories Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Dr. Reddy's Laboratories Azacitidine Drug Product Portfolios and Specifications
Table 99. Dr. Reddy's Laboratories Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Dr. Reddy's Laboratories Main Business
Table 101. Dr. Reddy's Laboratories Latest Developments
Table 102. MBA Pharmaceuticals Pvt Ltd Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Product Portfolios and Specifications
Table 104. MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. MBA Pharmaceuticals Pvt Ltd Main Business
Table 106. MBA Pharmaceuticals Pvt Ltd Latest Developments
Table 107. Taj Generics Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Taj Generics Azacitidine Drug Product Portfolios and Specifications
Table 109. Taj Generics Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Taj Generics Main Business
Table 111. Taj Generics Latest Developments
Table 112. Getwell Oncology Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Getwell Oncology Azacitidine Drug Product Portfolios and Specifications
Table 114. Getwell Oncology Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Getwell Oncology Main Business
Table 116. Getwell Oncology Latest Developments
Table 117. EVER Pharma Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. EVER Pharma Azacitidine Drug Product Portfolios and Specifications
Table 119. EVER Pharma Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. EVER Pharma Main Business
Table 121. EVER Pharma Latest Developments
Table 122. Xpreza Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Xpreza Azacitidine Drug Product Portfolios and Specifications
Table 124. Xpreza Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Xpreza Main Business
Table 126. Xpreza Latest Developments
Table 127. Shubham Pharmaceutical Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Shubham Pharmaceutical Azacitidine Drug Product Portfolios and Specifications
Table 129. Shubham Pharmaceutical Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Shubham Pharmaceutical Main Business
Table 131. Shubham Pharmaceutical Latest Developments
Table 132. Rizochem Pharmaceutical Basic Information, Azacitidine Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Rizochem Pharmaceutical Azacitidine Drug Product Portfolios and Specifications
Table 134. Rizochem Pharmaceutical Azacitidine Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Rizochem Pharmaceutical Main Business
Table 136. Rizochem Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Azacitidine Drug
Figure 2. Azacitidine Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Azacitidine Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Azacitidine Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Azacitidine Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Azacitidine Drug Sales Market Share by Country/Region (2024)
Figure 10. Azacitidine Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Vidaza®
Figure 12. Product Picture of Generic Vidaza®
Figure 13. Global Azacitidine Drug Sales Market Share by Type in 2025
Figure 14. Global Azacitidine Drug Revenue Market Share by Type (2020-2025)
Figure 15. Azacitidine Drug Consumed in Refractory anemia (RA)
Figure 16. Global Azacitidine Drug Market: Refractory anemia (RA) (2020-2025) & (K Units)
Figure 17. Azacitidine Drug Consumed in Refractory anemia with excess blasts (RAEB)
Figure 18. Global Azacitidine Drug Market: Refractory anemia with excess blasts (RAEB) (2020-2025) & (K Units)
Figure 19. Azacitidine Drug Consumed in Chronic myelomonocytic leukemia (CMMoL)
Figure 20. Global Azacitidine Drug Market: Chronic myelomonocytic leukemia (CMMoL) (2020-2025) & (K Units)
Figure 21. Azacitidine Drug Consumed in Others
Figure 22. Global Azacitidine Drug Market: Others (2020-2025) & (K Units)
Figure 23. Global Azacitidine Drug Sale Market Share by Application (2024)
Figure 24. Global Azacitidine Drug Revenue Market Share by Application in 2025
Figure 25. Azacitidine Drug Sales by Company in 2025 (K Units)
Figure 26. Global Azacitidine Drug Sales Market Share by Company in 2025
Figure 27. Azacitidine Drug Revenue by Company in 2025 ($ millions)
Figure 28. Global Azacitidine Drug Revenue Market Share by Company in 2025
Figure 29. Global Azacitidine Drug Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Azacitidine Drug Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Azacitidine Drug Sales 2020-2025 (K Units)
Figure 32. Americas Azacitidine Drug Revenue 2020-2025 ($ millions)
Figure 33. APAC Azacitidine Drug Sales 2020-2025 (K Units)
Figure 34. APAC Azacitidine Drug Revenue 2020-2025 ($ millions)
Figure 35. Europe Azacitidine Drug Sales 2020-2025 (K Units)
Figure 36. Europe Azacitidine Drug Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Azacitidine Drug Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Azacitidine Drug Revenue 2020-2025 ($ millions)
Figure 39. Americas Azacitidine Drug Sales Market Share by Country in 2025
Figure 40. Americas Azacitidine Drug Revenue Market Share by Country (2020-2025)
Figure 41. Americas Azacitidine Drug Sales Market Share by Type (2020-2025)
Figure 42. Americas Azacitidine Drug Sales Market Share by Application (2020-2025)
Figure 43. United States Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Azacitidine Drug Sales Market Share by Region in 2025
Figure 48. APAC Azacitidine Drug Revenue Market Share by Region (2020-2025)
Figure 49. APAC Azacitidine Drug Sales Market Share by Type (2020-2025)
Figure 50. APAC Azacitidine Drug Sales Market Share by Application (2020-2025)
Figure 51. China Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. India Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Azacitidine Drug Sales Market Share by Country in 2025
Figure 59. Europe Azacitidine Drug Revenue Market Share by Country (2020-2025)
Figure 60. Europe Azacitidine Drug Sales Market Share by Type (2020-2025)
Figure 61. Europe Azacitidine Drug Sales Market Share by Application (2020-2025)
Figure 62. Germany Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. France Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Azacitidine Drug Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Azacitidine Drug Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Azacitidine Drug Sales Market Share by Application (2020-2025)
Figure 70. Egypt Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Azacitidine Drug in 2025
Figure 76. Manufacturing Process Analysis of Azacitidine Drug
Figure 77. Industry Chain Structure of Azacitidine Drug
Figure 78. Channels of Distribution
Figure 79. Global Azacitidine Drug Sales Market Forecast by Region (2026-2031)
Figure 80. Global Azacitidine Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Azacitidine Drug Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Azacitidine Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Azacitidine Drug Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Azacitidine Drug Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Azacitidine Drug
Figure 2. Azacitidine Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Azacitidine Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Azacitidine Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Azacitidine Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Azacitidine Drug Sales Market Share by Country/Region (2024)
Figure 10. Azacitidine Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Vidaza®
Figure 12. Product Picture of Generic Vidaza®
Figure 13. Global Azacitidine Drug Sales Market Share by Type in 2025
Figure 14. Global Azacitidine Drug Revenue Market Share by Type (2020-2025)
Figure 15. Azacitidine Drug Consumed in Refractory anemia (RA)
Figure 16. Global Azacitidine Drug Market: Refractory anemia (RA) (2020-2025) & (K Units)
Figure 17. Azacitidine Drug Consumed in Refractory anemia with excess blasts (RAEB)
Figure 18. Global Azacitidine Drug Market: Refractory anemia with excess blasts (RAEB) (2020-2025) & (K Units)
Figure 19. Azacitidine Drug Consumed in Chronic myelomonocytic leukemia (CMMoL)
Figure 20. Global Azacitidine Drug Market: Chronic myelomonocytic leukemia (CMMoL) (2020-2025) & (K Units)
Figure 21. Azacitidine Drug Consumed in Others
Figure 22. Global Azacitidine Drug Market: Others (2020-2025) & (K Units)
Figure 23. Global Azacitidine Drug Sale Market Share by Application (2024)
Figure 24. Global Azacitidine Drug Revenue Market Share by Application in 2025
Figure 25. Azacitidine Drug Sales by Company in 2025 (K Units)
Figure 26. Global Azacitidine Drug Sales Market Share by Company in 2025
Figure 27. Azacitidine Drug Revenue by Company in 2025 ($ millions)
Figure 28. Global Azacitidine Drug Revenue Market Share by Company in 2025
Figure 29. Global Azacitidine Drug Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Azacitidine Drug Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Azacitidine Drug Sales 2020-2025 (K Units)
Figure 32. Americas Azacitidine Drug Revenue 2020-2025 ($ millions)
Figure 33. APAC Azacitidine Drug Sales 2020-2025 (K Units)
Figure 34. APAC Azacitidine Drug Revenue 2020-2025 ($ millions)
Figure 35. Europe Azacitidine Drug Sales 2020-2025 (K Units)
Figure 36. Europe Azacitidine Drug Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Azacitidine Drug Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Azacitidine Drug Revenue 2020-2025 ($ millions)
Figure 39. Americas Azacitidine Drug Sales Market Share by Country in 2025
Figure 40. Americas Azacitidine Drug Revenue Market Share by Country (2020-2025)
Figure 41. Americas Azacitidine Drug Sales Market Share by Type (2020-2025)
Figure 42. Americas Azacitidine Drug Sales Market Share by Application (2020-2025)
Figure 43. United States Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Azacitidine Drug Sales Market Share by Region in 2025
Figure 48. APAC Azacitidine Drug Revenue Market Share by Region (2020-2025)
Figure 49. APAC Azacitidine Drug Sales Market Share by Type (2020-2025)
Figure 50. APAC Azacitidine Drug Sales Market Share by Application (2020-2025)
Figure 51. China Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. India Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Azacitidine Drug Sales Market Share by Country in 2025
Figure 59. Europe Azacitidine Drug Revenue Market Share by Country (2020-2025)
Figure 60. Europe Azacitidine Drug Sales Market Share by Type (2020-2025)
Figure 61. Europe Azacitidine Drug Sales Market Share by Application (2020-2025)
Figure 62. Germany Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. France Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Azacitidine Drug Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Azacitidine Drug Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Azacitidine Drug Sales Market Share by Application (2020-2025)
Figure 70. Egypt Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Azacitidine Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Azacitidine Drug in 2025
Figure 76. Manufacturing Process Analysis of Azacitidine Drug
Figure 77. Industry Chain Structure of Azacitidine Drug
Figure 78. Channels of Distribution
Figure 79. Global Azacitidine Drug Sales Market Forecast by Region (2026-2031)
Figure 80. Global Azacitidine Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Azacitidine Drug Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Azacitidine Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Azacitidine Drug Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Azacitidine Drug Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Medical Thrombus Aspiration Catheter Market Growth 2024-2030
US$ 3,660.00
December 2024
134 pages
Global Retinoid Treatment for Skin Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
100 pages
Global Prefilled Sterile Water Syringes Market Growth 2023-2029
US$ 3,660.00
March 2023
96 pages
Global Starch Capsule Market Growth 2025-2031
US$ 3,660.00
May 2025
140 pages
Global Aerosol Mask Market Growth 2023-2029
US$ 3,660.00
March 2023
91 pages
